Nuvation Bio Inc (NUVB) PT Raised to $10 at Citizens on Safusidenib Plans
Tweet Send to a Friend
Citizens analyst Silvan Tuerkcan raised the price target on Nuvation Bio Inc (NYSE: NUVB) to $10.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
